Consultant, Pharmaceutical Services

Phone: +44(0)1751 432999
Country: United Kingdom

Peter Savin has over 40 years’ experience in the pharmaceutical industry, including a senior management career in multinational pharmaceutical companies. Prior to joining NSF, he was Vice President, Global QA for GSK.

Mr. Savin has experience in warning letter and consent decree remediation activities and is passionate about preventing the typical errors that organizations make when in this situation.

His areas of expertise include:

  • Leadership of the development and implementation of pharmaceutical quality, compliance, risk and corporate governance processes including:
    • Quality management systems
    • Deviation, root cause investigation and CAPA processes
    • Risk management and risk modeling
    • Auditing
    • Change management
    • Development of quality culture, human error prevention and behavioral GMP
  • Corporate change processes including organizational designs, mergers and downsizing
  • Strategic business perspective of quality, compliance, auditing, risk management and corporate governance processes across R&D, manufacturing and commercial operations

Mr. Savin is the editor of GMP Review, providing expert commentary on new and existing regulations in the pharmaceutical industry.